Activation of transcription factor NF-κB by the Tat protein of human immunodeficiency virus type

Journal of Virology

Volumn 70, Issue 7, 1996, Pages 4427-4437

  Demarchi, Francesca ^a   D'Adda di Fagagna, Fabrizio ^a   Falaschi, Arturo ^a   Giacca, Mauro ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEINASE INHIBITOR; RECOMBINANT PROTEIN; SALICYLATE SODIUM; TRANSACTIVATOR PROTEIN;

ARTICLE; ENHANCER REGION; GENE ACTIVATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LEUKEMIA CELL LINE; LONG TERMINAL REPEAT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DNA INTERACTION;

ANTIOXIDANTS; BASE SEQUENCE; CELL LINE, TRANSFORMED; DITHIOTHREITOL; DNA; DNA PRIMERS; DNA-BINDING PROTEINS; GENE EXPRESSION; GENE PRODUCTS, TAT; HELA CELLS; HIV-1; HUMANS; I-KAPPA B PROTEINS; KINETICS; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PROTEASE INHIBITORS; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; REPETITIVE SEQUENCES, NUCLEIC ACID; SODIUM SALICYLATE; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0029940987     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.7.4427-4437.1996     Document Type: Article

References (83)

1. Alcamí, J., T. Laín de Lera, L. Folgueira, M. A. Pedraza, J.-M. Jacqué, F. Bachelerie, A. R. Noriega, R. T. Hay, D. Harrich, R. B. Gaynor, J.-L. Virelizier, and F. Arenzana-Seisdos. 1995. Absolute dependence on κB responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes. EMBO J. 14:1552-1560.
2. Antoni, B. A., A. B. Rabson, A. Kinter, M. Bodkin, and G. Poli. 1994. NF-κB-dependent and -independent pathways of HIV activation in a chron- ically infected T cell line. Virology 202:684-694.
3. Baeuerle, P. A., and D. Baltimore. 1988. IκB: a specific inhibitor of the NF-κB transcription factor. Science 242:540-546.
4. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141-178.
5. Bagnarelli, P., S. Menzo, A. Valenza, A. Manzin, M. Giacca, F. Ancarani, G. Scalise, P. E. Varaldo, and M. Clementi. 1992. Molecular profile of human immunodeficiency virus infection in asymptomatic subjects and AIDS patients. J. Virol. 64:7328-7335.
6. Berkhout, B., A. Gatignol, A. B. Rabson, and K.-T. Jeang. 1990. TAR-independent activation of the HIV-1 LTR: evidence that Tat requires specific regions of the promoter. Cell 62:757-767.
7. Berkhout, B., and K. T. Jeang. 1992. Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 66:139-149.
8. Bielinska, A., R. A. Shivdasani, L. Q. Zhang, and G. J. Nabel. 1990. Regulation of gene expression with double-stranded phosphorothioate oligonucleotides. Science 250:997-1000.
9. Biswas, D. K., C. M. Ahlers, B. J. Dezube, and A. B. Pardee. 1993. Cooperative inhibition of NF-κB and Tat-induced superactivation of human immunodeficiency virus type 1 long terminal repeat. Proc. Natl. Acad. Sci. USA 90:11044-11048.
10. Brown, K., S. Park, T. Kanno, G. Franzoso, and U. Siebenlist. 1993. Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκB-α. Proc. Natl. Acad. Sci. USA 90:2532-2536.
11. Buonaguro, L., G. Barillari, H. Chang, C. A. Bohan, V. Kao, R. Morgan, R. C. Gallo, and B. Ensoli. 1992. Effects of human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. J. Virol. 46:7159-7167.
12. Buonaguro, L., F. M. Buonaguro, G. Giraldo, and B. Ensoli. 1994. The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure. J. Virol. 68:2677-2682.
13. Chiang, C. M., and R. G. Roeder. 1995. Cloning of an intrinsic human TFIID subunit that interacts with multiple transcriptional activators. Science 267:531-536.
14. Chirmule, N., S. Than, S. A. Khan, and S. Pahwa. 1995. Human immunodeficiency virus Tat induces functional unresponsiveness in T cells. J. Virol. 69:492-498.
15. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
16. Cullen, B. R. 1992. Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiol. Rev. 56:375-394.
17. Cupp, C., J. P. Taylor, K. Khalili, and S. Amini. 1993. Evidence for stimulation of the transforming growth factor beta 1 promoter by HIV-1 Tat in cells derived from CNS. Oncogene 8:2231-2236.
18. 17a.Demarchi, F., et al. Submitted for publication.
19. Demarchi, F., P. D'Agaro, A. Falaschi, and M. Giacca. 1992. Probing protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1 by in vivo footprinting. J. Virol. 66:2514-2518.
20. Demarchi, F., P. D'Agaro, A. Falaschi, and M. Giacca. 1993. In vivo footprinting analysis of constitutive and inducible protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1. J. Virol. 67:7450-7460.
21. Diviacco, S., P. Norio, L. Zentilin, S. Menzo, M. Clementi, G. Biamonti, S. Riva, A. Falaschi, and M. Giacca. 1992. A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates. Gene 122:313-320.
22. Drysdale, C. M., and G. N. Pavlakis. 1991. Rapid activation and subsequent down-regulation of the human immunodeficiency virus type 1 promoter in the presence of Tat: possible mechanisms contributing to latency. J. Virol. 65:3044-3051.
23. Duh, E. J., W. J. Maury, T. M. Folks, A. S. Fauci, and A. B. Rabson. 1989. Tumor necrosis factor a activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-κB sites in the long terminal repeat. Proc. Natl. Acad. Sci. USA 86:5974-5978.
24. Ensoli, B., G. Barillari, S. Z. Salahuddin, R. C. Gallo, and F. Wong-Staal. 1990. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature (London) 345:84-87.
25. Ensoli, B., L. Buonaguro, G. Barillari, V. Fiorelli, R. Gendelman, R. A. Morgan, P. Wingfield, and R. C. Gallo. 1993. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67:277-287.
26. Feinberg, M. B., R. F. Jarrett, A. Aldovini, R. C. Gallo, and F. Wong-Staal. 1986. HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. Cell 46:807-817.
27. Felber, B. K., and G. N. Pavlakis. 1988. A quantitative bioassay for HIV-1 based on transactivation. Science 239:184-186.
28. Frankel, A. D., and C. O. Pabo. 1988. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55:1189-1193.
29. Giacca, M., M. I. Gutierrez, S. Menzo, F. d'Adda di Fagagna, and A. Falaschi. 1992. A human binding site for transcription factor USF/MLTF mimics the negative regulatory element of human immunodeficiency virus type 1. Virology 186:133-147.
30. Grassi, G., L. Zentilin, S. Tafuro, S. Diviacco, A. Ventura, and M. Giacca. 1994. A rapid procedure for the quantitation of low abundance mRNAs by competitive RT-PCR. Nucleic Acids Res. 22:4547-4549.
31. Griffin, G. E., K. Leung, T. M. Folks, S. Kunkel, and G. J. Nabel. 1989. Activation of HIV gene expression during monocyte differentiation by induction of NF-κB. Nature (London) 339:70-73.
32. Harrich, D., J. Garcia, R. Mtsuyasu, and R. Gaynor. 1990. Tar independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes. EMBO J. 9:4417-4423.
33. Helland, D. E., J. L. Welles, A. Caputo, and W. A. Haselline. 1991. Transcellular transactivation by the human immunodeficiency virus type 1 Tat protein. J. Virol. 65:4547-4549.
34. Henkel, T., T. Machleidt, I. Alkalay, M. Kronke, V. Ben-Neriah, and P. A. Baeuerle. 1993. Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB. Nature (London) 365:182-185.
35. Herrmann, C. H., and A. P. Rice. 1995. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor. J. Virol. 69:1612-1620.
36. Howcroft, K., K. Strebel, M. A. Martin, and D. S. Singer. 1993. Repression of MHC class I gene promoter activity by two-exon Tat of HIV. Science 260:1320-1322.
37. Jeang, K. T., R. Chun, N. H. Lin, A. Gatignol, C. G. Glabe, and H. Fan. 1993. In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor. J. Virol. 67:6224-6233.
38. Jones, K. A., and B. M. Peterlin. 1994. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:717-743.
39. Kamine, J., T. Subramian, and G. Chinnadurai. 1991. Sp-1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein. Proc. Natl. Acad. Sci. USA 88:8510-8514.
40. Kashanchi, F., G. Piras, M. F. Radonovich, J. F. Duvall, A. Fattaey, C. M. Chiang, R. G. Roeder, and J. N. Brady. 1994. Direct interaction of human TFIID with the HIV-1 transactivator Tat. Nature (London) 367:295-299.
41. Kopp, E., and S. Ghosh. 1994. Inhibition of NF-κB by sodium salicylate and aspirin. Science 265:956-959.
42. Li, C., C. Lai, D. S. Singman, and R. B. Gaynor. 1991. Cloning of a cellular factor, interleukin binding factor, that binds to a NFAT-like motifs in the human immunodeficiency virus long terminal repeat. Proc. Natl. Acad. Sci. USA 88:7739-7743.
43. Li, C. J., D. J. Friedman, C. Wang, V. Metelev, and A. B. Pardee. 1995. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 268:429-431.
44. Liu, J., N. Perkins, R. Schmid, and G. Nabel. 1992. Specific NF-κB subunits act in concert with Tat to stimulate human immunodeficiency type 1 transcription. J. Virol. 66:3883-3887.
45. Lotz, M., I. Clark-Lewis, and V. Ganu. 1994. HIV-1 transactivator protein Tat induces proliferation and TGF beta expression in human articular chondrocytes. J. Cell Biol. 124:365-371.
46. Mann, D. A., and A. D. Frankel. 1991. Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J. 10:1733-1739.
47. Masood, R., Y. Lunardi-Iskandar, T. Moudgil, Y. Zhang, R. E. Law, C. L. Huang, R. K. Puri, A. M. Levine, and P. S. Gill. 1994. IL-10 inhibits HIV-1 replication and is induced by tat. Biochem. Biophys. Res. Commun. 202:374-383.
48. Mueller, P. R., and B. Wold. 1989. In vivo footprinting of a muscle specific enhancer by ligation mediated PCR. Science 246:780-786.
49. Nabel, G., and D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (London) 326:711-713.
50. Nabel, G. J., S. A. Rice, D. M. Knipe, and D. Baltimore. 1988. Alternative mechanisms for activation of human immunodeficiency virus enhancer in T cells. Science 239:1299-1302.
51. 49a.Nolan, G. Personal communication.
52. Osborn, L., S. Kunkel, and G. J. Nabel. 1989. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc. Natl. Acad. Sci. USA 86:2336-2340.
53. Pahl, H. L., and P. A. Baeuerle. 1995. Expression of influenza virus hemagglutinin activates transcription factor NF-κB. J. Virol. 69:1480-1484.
54. Pantaleo, G., C. Graziosi, J. F. Demarest, L. Butini, M. Montroni, C. H. Fox, J. M. Orenstein, D. P. Kotler, and A. S. Fauci. 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (London) 362:355-358.
55. Peterlin, B. M., M. Adams, A. Alonso, A. Baur, S. Ghosh, X. Lu, and Y. Luo. 1993. Tat trans-activator, p. 74-96. In B. R. Cullen (ed.), Human retroviruses. IRL Press, Oxford.
56. Puri, R. K., and B. B. Aggarwal. 1992. Human immunodeficiency virus type 1 tat gene up-regulates interleukin 4 receptors on a human B-lymphoblastoid cell line. Cancer Res. 52:3787-3790.
57. Qian, J., V. Bours, J. Manischewitz, R. Blackburn, U. Siebenlist, and H. Golding. 1994. Chemically selected subclones of the CEM cell line demonstrate resistance to HIV-1 infection resulting from a selective loss of NF-kappa B DNA binding proteins. J. Immunul. 152:4183-4191.
58. Rhim, H., F. Chan, C. O. Echetebu, and A. P. Rice. 1993. Rapid purification of monomer HIV-2 Tat protein expressed in Escherichia coli. Protein Express. Purif. 4:24-31.
59. Roy, S., M. G. Katze, N. T. Parkin, I. Edery, A. G. Hovanessian, and N. Sonenberg. 1990. Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product. Science 247:1216-1219.
60. Sabatier, J. M., E. Vives, K. Mabrouk, A. Benjouad, H. Rochat, A. Duval, B. Hue, and E. Bahraoui. 1991. Evidence for neurotoxic activity of Tat from human immunodeficiency virus type 1. J. Virol. 65:961-967.
61. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory. Cold Spring Harbor, N.Y.
62. Sastry, K. J., H. R. Reddy, R. Pandita, K. Totpal, and B. B. Aggarwal. 1990. HIV-1 tat gene induces tumor necrosis factor-beta (lymphotoxin) in a human B-lymphoblastoid cell line. J. Biol. Chem. 265:20091-20093.
63. Scala, G., M. R. Ruocco, C. Ambrosino, M. Mallardo, V. Giordano, F. Baldassarre, E. Dragonetti, I. Quinto, and S. Venuta. 1994. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein. J. Exp. Med. 179:961-971.
64. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10:405-455.
65. Subramanyam, M., W. G. Gutheil, W. W. Bachovchin, and B. T. Huber. 1993. Mechanism of HIV-1 Tat induced inhibition of antigen-specific T cell responsiveness. J. Immunol. 150:2544-2553.
66. Sun, S. C., P. A. Ganchi, D. W. Ballard, and W. C. Greene. 1993. NF-κB controls expression of inhibitor IκB-α: evidence for an inducible autoregulatory pathway. Science 259:1912-1915.
67. Sune, C., and M. A. Garcia-Blanco. 1995. Transcriptional transactivation by human immunodeficiency virus type 1 Tat requires specific coactivators that are not basal factors. J. Virol. 69:3098-3107.
68. Suñé, C., and M. A. García-Blanco. 1995. Sp1 transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 69:6572-6576.
69. Suzuki, T., H. Hirai, T. Murakami, and M. Yoshida. 1995. Tax protein of HTLV-1 destabilized the complexes of NF-κB and IκB-α and induces nu- clear translocation of NF-κB for transcriptional activity. Oncogene 10:1199-1207.
70. Taylor, J. P., C. Cupp, A. Diaz, M. Chowdhury, K. Khalili, S. A. Jimenez, and S. Amini. 1992. Activation of expression of genes coding for extracellular matrix proteins in Tat-producing glioblastoma cells. Proc. Natl. Acad. Sci. USA 89:9617-9621.
71. Taylor, J. P., M. Kundu, and K. Khalili. 1993. Tar-independent activation of HIV-1 requires the activation domain hut not the RNA-binding domain of Tat. Virology 195:780-785.
72. Tong-Starksen, S. E., P. A. Luciw, and B. M. Peterlin. 1987. Human immunodeficiency virus long terminal repeat responds to T-cell activation signals. Proc. Natl. Acad. Sci. USA 84:6845-6849.
73. Ursini, M. V., T. Lettieri, M. Braddock, and G. Martini. 1993. Enhanced activity of human G6PD promoter transfected in HeLa cells producing high levels of HIV-1 Tat. Virology 196:338-343.
74. Valerie, K., A. Delers, C. Bruck, C. Thiriart, H. Rosenberg, C. Debouck, and M. Rosenberg. 1988. Activation of human immunodeficiency virus type 1 by DNA damage in human cells. Nature (London) 333:78-81.
75. Viscidi, R. P., K. Mayur, H. M. Lederman, and A. D. Frankel. 1989. Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. Science 246:1606-1608.
76. Vlach, J., and P. M. Pitha. 1992. Activation of human immunodeficiency virus type 1 provirus in T-cells and macrophages is associated with induction of inducer-specific NF-κB binding proteins. Virology 187:63-72.
77. Westendorp, M. O., R. Frank, C. Ochsenbauer, K. Stricker, J. Dhein, H. Walczak, K. M. Debatin, and P. H. Krammer. 1995. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature (London) 375:497-500.
78. Westendorp, M. O., M. Li-Weber, R. W. Frank, and P. H. Krammer. 1994. Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells. J. Virol. 68:4177-4185.
79. Westendorp, M. O., V. A. Shatrov, K. Schulze-Osthoff, R. Frank, M. Kraft, M. Los, P. H. Krammer, W. Droge, and V. Lehmann. 1995. HIV-1 Tat potentiates TNF-induccd NF-κB activation and cytotoxicity by altering the cellular redox state. EMBO J. 14:546-554.
80. Yu, L., P. M. Loewenstein, Z. Zhang, and M. Green. 1995. In vitro interaction of the human immunodeficiency virus type 1 Tat transactivator and the general transcription factor TFIIB with the cellular protein TAP. J. Virol. 69:3017-3023.
81. Zauli, G., B. R. Davis, M. C. Re, G. Visani, G. Furlini, and M. La Placa. 1992. Tat protein stimulates production of transforming growth factor-beta 1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression. Blood 80:3036-3043.
82. Zauli, G., D. Gibellini, D. Milani, M. Mazzoni, P. Borgatti, M. La Placa, and S. Capitani. 1993. Human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis. Cancer Res. 53:4481-4485.
83. Zhou, Q., and P. A. Sharp. 1995. Novel mechanism and factor for regulation by HIV-1 Tat. EMBO J. 14:321-328.